Oestrogens as direct modulators of cell behaviors in development
The original dogma of steroid hormone-dependent brain 'organisation' or sexual differentiation assumed that the activation of nuclear steroid receptors initiated genomic signalling events. Steroid hormones would presumably bind to nuclear steroid receptor superfamily members [e.g. oestrogen receptor (ER)a or ERb] that would act via hormone response elements at the promoters of select genes to activate or inhibit new protein transcription and subsequent translation. Although this is likely to comprise the predominant mechanism of steroid influences, other molecular mechanisms may also contribute to steroid activated sexual differentiation. For example, many recently identified proteins that are not members of the steroid receptor superfamily are thought to bind steroid hormones (5, 6) . Many of these steroid hormone-binding proteins are not located in cell nuclei and have been shown to promote cell signalling through classical second messenger signal transduction cascades involving either protein phosphorylation or calcium entry into the cell (7) . Additionally, some events modulated by steroid hormones take place either too quickly to be regulated by changes in transcription or cannot be blocked by transcriptional inhibitors (6) .
There is increasing evidence that sexually dimorphic brain characteristics may derive, in part, from genetic sex and ⁄ or hormone influences on neuronal migration. In our studies, we have found several lines of evidence that suggest that gonadal steroid hormones influence the movements and positions of identified cells in the embryonic brain. Early indirect evidence came from the discovery of sex differences and hormone dependence of antigen expression in radial cell fibers within the preoptic area ⁄ anterior hypothalamus (POA ⁄ AH) of rats (8) . Because these cells are likely important for neuronal migration, we hypothesised that sex differences in the molecular characteristics of these cells would translate into differences in migration. The first direct demonstration of sex differences in cell migration within the developing mouse POA ⁄ AH came from an examination of migratory characteristics of randomly labelled cells using the carbocyanine dye DiI (9) . At the same time, in an avian model, oestradiol was also shown to influence cell movements in brain (10) . More recently, we examined the direct effect of oestradiol on neurone migration in vitro by tracking the movement of fluorescent cells expressing yellow fluorescent protein under the control of a Thy1 promoter in organotypic brain slices (11) . Oestradiol administration caused rapid changes in cell movement characteristics in a region specific manner, whereas exposure of these cells to dihydrotestosterone did not affect cell motions or interfere with the subsequent influence of oestradiol.
Finding an influence of a sex steroids on cell movements begs the question of the mechanisms through which they act, as well as which receptor(s) might be activated. There are a number of candidate proteins that bind oestradiol (5, 6) , although it has been argued that many, if not all, known non-genomic actions of oestradiol can be attributed to the actions of ERa or ERb acting at extranuclear sites (12) . In early work, we localised immunoreactive ERa to cell nuclei in the same region that we have seen sex differences or hormone influence on cell movements (9) . To date, however, we have been unable to co-localise ERa specifically to cells whose movement characteristics are influenced by hormone administration in vitro (11) . The question therefore remains as to whether expression of ERa or ERb, below the sensitivity of current detection methods, exist on neuronal cell membranes during development, or whether other mediators are involved in transducing oestrogendependent changes in neurone migration.
For hormones to impact neuronal migration early in development, all necessary signalling components must be present at appropriate times. The primary steroid effector in the development of sexually dimorphic features in the rodent brain is hypothesised to be oestradiol (13) . Alpha-fetoprotein (AFP), a steroid binding protein present in both embryonic male and female rodents, prevents direct access of oestradiol to cells in the brain. AFP does not bind testosterone that is free to enter the brain, where it can be converted to oestradiol by cytochrome p450-aromatase. For oestradiol signalling to impact neurone migration in the developing brain, both aromatase activity and proper expression of the downstream signal transduction components must occur in temporally and spatially specific patterns. For example, sex differences in basal movement of neurones in vitro were evident in slices derived from brains at embryonic day E14 (11) and E15 (9), but not E13 (11) . This suggests that alterations of migratory characteristics may be one of the first influences of gonadal steroids for brain sexual differentiation. Because administration of oestradiol was able to influence cell movements in slices created on E13, it further suggests that the hormone-responsive machinery might be in place prior to the initial exposure to steroid hormones that occurs after the formation of the gonads (approximately E12.5 in mice).
If sex differences and hormone influences alter cell motions (and thereby migration), then there should be an increasing number of sexual dimorphisms identified based on the positions of cells. One example is a sex difference in the location of cells expressing either ERb or the R1 subunit (GABA B R1) of the gamma-aminobutyric acid (GABA) B receptor in the POA ⁄ AH of mice at E17 (14) . The location of each subset of cells containing immunoreactive ERb or GABA B R1 at E17 was sex dependent, even though the total number of cells did not differ by sex. Immunoreactive ERb cells were located more ventrally and medially in males than in females and immunoreactive GABA B R1 neurones were located more ventrally in males than in females. The area in which these differences were noted corresponds to the location where oestradiol was found to decrease the rate and frequency of movement of yellow fluorescent protein-positive cells (11) . In adult mice, the location of cells containing immunoreactive neuronal nitric oxide synthase (nNOS) appeared to be spread more laterally in the POA ⁄ AH of ERa gene disrupted males compared to wild-type (15) . In rats, a sex difference was detected in the location of immunoreactive ERb neurones in the anteroventral periventricular nucleus (16) . In this case, immunoreactive ERb neurones were located more laterally in males than in females. Interestingly, this difference was reversed by neonatal orchidectomy of males or oestradiol treatment of females, providing further evidence of steroid hormones directly affecting the position of specific neurones.
Steroid signalling for cell movements in non-neural cells
There is a long history of rapid steroid hormone signalling and localisation of steroid hormone receptors to compartments other than nuclei (12) . There is also strong evidence of sex steroid influences on cell movements in non-neural circumstances, including cancer metastasis, angiogenesis, vascular cell remodeling, wound healing, and the control of inflammation (17) . For its role in metastasis, ER signalling (via ERa) may utilise the actin binding protein moesin as a key partner for modifying the cytoskeleton to promote migration (18) . Moesin is part of the ezrin-radixin-moesin family of actin binding proteins that has potential functions in brain development (19) , but has not been investigated for hormone interactions in brain. Oestrogenic signalling may not require either ERa or ERb if oestradiol is metabolised to 2-methoxy-oestradiol. This metabolite of oestradiol has been implicated in altering cell motility, migration and adhesion by interfering with cytoskeletal function through other mechanisms (20, 21) . Another migratory factor that has sexually differentiated expression is macrophage migration inhibitory factor (MIF). MIF is a mediator of delayed healing in several species. Surprisingly, the effectiveness of MIF is sexually dimorphic, and is regulated by steroid hormones in adulthood (22) .
Other signalling molecules that might mediate hormonal modulation of cell movements
GABA
Although direct effects of steroid hormones such as oestradiol on cell motions might be considered 'atypical', the effects of steroid hormones may occur through other molecules that are more frequently thought to influence cell migration (Fig. 1) . Several neurotransmitters (including, GABA, serotonin, dopamine and endogenous opiates) have been suggested to act as neurotrophic factors or morphogens in various brain regions (23, 24) . Of those molecules that might be considered major effectors of hormone action, the neurotransmitter GABA might be particularly important in hypothalamic development (25, 26) . The focus of several of our studies has examined the effects of GABA on the development of hypothalamic nuclear groups, specifically the ventromedial (VMN) and paraventricular (PVN) nuclei of the hypothalamus. The distribution of GABAergic elements surrounding these developing nuclei may be essential for the arrangement of the cytoarchitecture in these regions [VMN (26) ; PVN (27) ]. Several lines of evidence suggest that GABA plays a role in the embryonic differentiation of the VMN. First, GABA is synthesised in positions that could potentially provide boundary information for the embryonic VMN (28) . Second, disrupting the steroidogenic factor-1 (SF-1) gene disrupts the distribution of GABAergic elements that normally surrounds the VMN prior to its organisation (29) . This may partially contribute to the altered distribution of numerous phenotypically identified cells in the VMN of SF-1 knockout mice (29, 30) . Third, activation of GABA A receptors affected cell movements and the distribution of identified cells in the region of the VMN (31) . Activation of GABA B receptors also decreased cell movements in the region of the VMN (32) . Finally, antagonism of GABA B action, either pharmacologically in vitro or by genetic disruption of the GABA B R1 subunit of the receptor, also affected cell movement and the distribution of immunoreactive ERa-containing cells in the ventrolateral VMN (33) . Although the specifics of GABA A and GABA B receptor actions may differ, likely due to differences in their molecular mechanisms, strong indications of morphogenetic roles for GABA have been characterised in the developing cerebral cortex (34) (35) (36) (37) .
GABAergic neurones are likely to be direct targets of steroid hormone actions because co-localisation has been noted with both steroid binding (38) and immunoreactive receptors (39, 40) . Perinatal administration of the GABA A receptor agonists muscimol and diazepam have resulted in sex-related morphological changes in several brain regions (41, 42) . In locations where GABAergic inhibitory input to cells of the PVN has been characterised in adults (43) , there is a large population of cells containing immunoreactive ERa at early ages in development. These GABAergic cells are likely targets of steroid hormone action, and may have an important role in the development of the PVN (27) .
Nitric oxide
Another potential molecular effector of differentiation is nitric oxide (NO), which is a product of the enzymatic conversion of L-arginine to citrulline. NO plays many roles in development as well as in adulthood. NO has been suggested to help direct cell migration, cell proliferation and survival (44) (45) (46) , which are all important factors for sexual differentiation. Because NO is a highly reactive molecule that is difficult to isolate in vivo, many studies evaluate nitric oxide synthase (NOS) expression as an indicator of the location of NO (48, 49) and immunoreactive nNOS cells in mice (15, 50, 51) . We recently examined the distribution of immunoreactive nNOS containing cells in developing mice and found sex differences in locations that may contribute to the development of sex differences in hypothalamic development (52).
Brain-derived neurotrophic factor
Another potential mediator of hormone actions on cell movements during development is brain-derived neurotrophic factor (BDNF). Data from brain regions other than hypothalamus suggested a role for BDNF in cell migration (53) . It is highly expressed in restricted regions of the developing hypothalamus (54, 55) . The BDNF gene promoter contains a consensus regulatory region for ERs (56) and oestradiol has been shown to increase the release of BDNF from specific cell types (57) . BDNF expression specifically in the VMN has been shown to depend upon circulating gonadal steroids (58 
Cyclic AMP response element binding protein
It is interesting to note that several signalling systems already highlighted to be important for sexual differentiation may converge on the phosphorylation of the cyclic AMP response element binding protein (CREB). CREB phosphorylation in hypothalamic cells has been noted for sex differences (60, 61) and hormone influences (62) . The site of CREB phosphorylation may play an important role in the activity of CREB binding protein and its ability to influence gene transcription. Historically, phosphorylated CREB (pCREB) involves phosphorylation at serine 133; however, calcium influx can induce phosphorylation of CREB at two additional locations (Ser142 and Ser143), along with serine 133, which then inhibit pCREB interaction with CREB-binding protein (63) . During development, GABA may influence calcium influx and therefore downstream phosphorylation of CREB and pCREB activity. Treatment with the GABA A agonist, muscimol, induced a sex difference in pCREB, which was blocked by an L-type voltage gated calcium channel blocker nimodipine (64) . The identification of this effect highlights calcium influx as an interesting target for sexual differentiation via GABA signalling (65) . GABA signalling also affects expression of BDNF and nNOS via CREB-dependent mechanisms (65, 66) . In turn, BDNF may drive CREB dependent gene expression in a NO-dependent manner (67) . This complex interaction of signal transduction pathways is impacted by gonadal steroid hormones at all levels, supporting the hypothesis that these pathways may play an important role in the modulation of sex specific differences in neurone migration during development.
Sexual dimorphisms following disruption of normal development
Although a majority of sex differences are a direct consequence of hormone actions, some may only be revealed following either genetic or environmental disruptions. Identification of these sexual dimorphisms allows both insight into the mechanisms behind normal brain development, and potential side effects of disruption on adult phenotypes. Although there are a number of indications of sex differences in PVN regulation and function (68, 69) , there are relatively few findings of sexual dimorphism (based on cytoarchitecture or anatomy) in the perinatal or adult PVN. One of the few demonstrations of sexual dimorphism in the PVN is a difference in the number of corticotrophin-releasing hormone (CRH) containing neurones in the brains of human subjects. Men had more immunoreactive CRH neurones than women in the PVN, and men, but not women, had a significant increase in the number of immunoreactive CRH neurones with age (70) . We recently noted an additional sex difference in the PVN of mice with respect to the positioning of cells containing immunoreactive ERa that was only revealed when GABA B receptor signalling was impaired (27) . Some sex differences in the PVN may only become apparent during specific physiological states or under circumstances of altered development.
Conclusions
Sex differences in the positions of cells in the developing hypothalamus and steroid hormone influences on cell movements in vitro suggest that cell migration may be one target for early molecular actions that impact brain development and sexual differentiation. A potential relationship exists between steroid hormone signalling and various other signalling molecules described above (NO, GABA, BDNF and CREB). Future experiments will be important for directly testing the interactions of these signalling molecules as they relate to hypothalamic development. . Although SF-1 is important in VMN development, our prior work and work of others suggests that other factors, in particular, GABA are also likely to be involved in determining the boundaries of the nucleus by influencing the movement characteristics of migrating neurons. The neurotransmitter GABA has an interesting relationship with the development of the VMN . During early stages of development, GABA is synthesized in positions that could provide potential boundary information for the embryonic VMN. GABAergic neurons and fibers surround the embryonic VMN, and toward the end of gestation in mice, GABAergic fibers begin to infiltrate interior regions of the VMN . In contrast to the late gestational in-growth of fibers, subunits for GABA A , and GABA B receptors are expressed in neurons within the region of the VMN as early as E13 and throughout adulthood. In addition, physiological analyses have been performed as early as E18 and indicate the presence of functional receptors in the developing mediobasal hypothalamus of rats van den Pol, 1995, 1998) .
GABA
In addition to its role as the major inhibitory neurotransmitter in the adult CNS, GABA is also important in many developmental processes, including cell proliferation (LaMantia, 1995) and neuronal migration Manent and Represa, 2007 ). GABA's influence on migration can be mediated through either or both its A and B receptors. In cortical migration, GABA A and GABA B receptors play a role in the formation of cortical layers . Data to date indicate that the ability of GABA to influence neuronal migration within the VMN is mediated by both ionotropic GABA A ( . Baclofen administration did not change the probability of cells moving nor did it have an effect on the angle of cell movement. Based on the Nissl-stained gross cytoarchitecture, baclofen did not influence the ability of the VMN to form.
The current study further examines the role of GABA B receptors in the development of the embryonic and early postnatal murine VMN and compares the role of these receptors on the development of the neighboring arcuate nucleus (ARC). Mice in which the Thy-1 promoter drives neuron-selective yellow fluorescent protein (YFP) expression (Feng et al., 2000) , were utilized for live video microscopy studies in vitro to evaluate the potential role of endogenous GABA acting at GABA receptors on the movement of one population of migrating neurons (Thy-1/YFP expressing neurons) by using GABA receptor antagonists. These mice were used as a tool to follow the movement patterns of fluorescently labeled cells in the regions of the VMN and ARC. It is unknown as to why YFP expression is found in a subset of VMN and ARC neurons at embryonic ages, but the limited pattern of expression is likely due to the insertion site of the transgene, the number of copies incorporated into each line, or the interactions of the transgene elements with flanking DNA (Feng et al., 2000) . GABA B receptor knockout mice (Prosser et al., 2001 ) were utilized to determine the dependence of VMN formation on GABA B signaling during early development. Immunocytochemistry and in situ hybridization were used to identify cell phenotypes for ER␣, BDNF (brain-derived neurotrophic factor), SF-1, and specific GABA A receptor subunits to determine potential differences in cell position or expression in mice without GABA B receptor signaling.
EXPERIMENTAL PROCEDURES Animals
Two lines of transgenic mice were used for the experiments in this study. GABA B R1 heterozygous breeding pairs obtained from GlaxoSmithKline (Middlesex, UK) were used to generate knockout, heterozygous, and wild type mice at multiple developmental ages. Mice with disruption of GABA B receptor signaling were generated on a C57BL/6 background through the insertion of a gene encoding ␤-galactosidase in the coding region of the R1 subunit of the GABA B receptor (Prosser et al., 2001 ). Another line of transgenic mice obtained from Jackson Laboratory (B6.CgTg(Thy1-YFP)16Jrs/J; Bar Harbor, ME, USA) was created on a C57BL/6 background with the Thy-1 promoter driving YFP expression (Feng et al., 2000) . The Thy-1 promoter in this transgenic line drives neuronal expression in the brain, including the ARC and VMN, in a spatially and temporally regulated manner during development (Tobet et al., 2003; . GABA B R1 heterozygote mice were crossed with Thy-1/YFP mice to begin to generate a line of GABA B R1 knockout and heterozygote mice that also contain fluorescently labeled YFP neurons. Animals were mated overnight and females were checked for vaginal plugs the following morning. The day of plug was designated as E0 and mice were taken at ages E15, E17, postnatal day (P) 0 (counted as day of birth, occurring at E19), and P4. Pregnant dams were anesthetized using ketamine (80 mg/kg) and xylazine (8 mg/kg) and embryos were removed by cesarean section one at a time. Crown-to-rump lengths were measured to verify developmental age, weights were taken for comparison, and tissue was taken for genotyping by PCR. P0 and P4 pups were anesthetized on ice and pups were perfused transcardially with either 4 ml (E17) or 5 ml (P0 and P4) of 4% paraformaldehyde. Heads were postfixed overnight in 4% paraformaldehyde and changed into 0.1 M phosphate buffer (PB) the following day. Heads were stored in 0.1 M PB at 4°C until used for immunocytochemistry or in situ hybridization. All experiments were done to minimize suffering and the number of animals used. Experiments were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the Colorado State University Animal Care and Use Committee.
Genotyping
Tail DNA was extracted using a base extraction method: incubation at 95°C with 0.05 M NaOH for 20 min, 10 min at room temperature (RT), followed by addition of a Tris NaOH solution (pH 8.0) and stored at Ϫ20°C. Mice carrying the GABA B R1 (GenBank accession number NW001470 (Kaupmann et al., 1997)) knockout allele were genotyped using standard Taq polymerase PCR kit (Qiagen; Valencia, CA, USA). The PCR cycling conditions consisted of 20 s of denaturation at 94°C followed by 20 s of annealing at 56°C and 1 min of extension at 72°C. This was repeated for 35 cycles. GABA B R1 primer sets used consisted of a KO insert forward primer (CGCCTTCTTGACGAGTTCT), a WT-specific forward primer (CTCCCGAGAGTGACTGGTT) and a common reverse primer (GCCCTCTTGCCTCTCTAAA). Animals were designated as wild type, heterozygous, or knockouts. Wild type and heterozygous animals had no detectable differences on any measure and were grouped together as controls. For video microscopy studies, mice were either heterozygous or homozygous for the Thy1-YFP allele. PCR cycling conditions for YFP genotyping consisted of 30 s of denaturation at 94°C followed by 1 min of annealing at 56°C and 1 min of extension at 72°C. This was repeated for 35 cycles. YFP primer sets included a forward primer (AAGTTCATCTGCACCACCG) and a reverse primer (TCCTTGAAGAAGATGGTGCG). Sex determination was done using PCR for the Y chromosome encoded Sry gene as described previously (Luo et al., 1994) .
Immunocytochemistry and in situ hybridization
For immunocytochemical experiments brains were dissected out of the head, embedded in 5% agarose, and cut into 60 m thick sections using a vibrating microtome (VT1000S; Leica Microsystems, Wetzlar, Germany). Alternating sections were collected in 0.05 M phosphate-buffered saline (PBS) and incubated with primary antisera. Rabbit polyclonal antisera directed against ER␣ was obtained from Upstate Biotechnology (C1355; Charlottesville, VA, USA) and was diluted to 1/5000 for brightfield detection and 1/1000 for epifluorescence. Other rabbit polyclonal antibodies obtained include SF-1 (graciously provided by Dr. Ken Morohashi; diluted 1/1000), GABA A receptor subunit ␤3 (graciously provided by W. Sieghart (Sperk et al., 1997); 0.045 g/ml), GABA A receptor subunit ␣1 (Phosphosolutions, Aurora, CO, USA; diluted 1/200), and green fluorescent protein (GFP; Molecular Probes/Invitrogen, Carlsbad, CA, USA; diluted 1/50,000). A chicken polyclonal GFP antibody was also used for dual label epifluorescence (ckGFP; Chemicon International, Temecula, CA, USA; diluted 1/1000). Guinea-pig polyclonal antisera directed against GABA B R1 (GP311) were generously provided by Dr. Marta Margeta-Mitrovic . Briefly, sections were washed in 0.05 M PBS with 0.1 M glycine for 30 min followed by a series of rinses with PBS. The sections were then placed in a 0.5% solution of sodium borohydride in PBS, rinsed in PBS, and incubated in a PBS blocking solution containing 5% normal goat serum, 0.3% Triton X-100 (Tx)/PBS and 1% H 2 O 2 . Primary antibodies were diluted in a PBS buffer containing 1% bovine serum albumin and 0.3% Tx. The sections were then placed in primary antibody for two to three nights at 4°C. Following the incubation in primary antibody, all steps were done at RT. Sections were rinsed four times in a PBS/1% normal goat serum solution containing 0.02% Tx, and then incubated in secondary antibody for 2 h. The secondary antibodies were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA) and were diluted in a PBS solution containing 1% normal goat serum and 0.32% Tx. Following this incubation the sections were rinsed four times in a PBS/0.02% Tx solution. For brightfield detection a 1:2500 dilution of peroxidase conjugated streptavidin in 0.32% Tx/PBS was placed on the tissue sections for 1 h. The sections were rinsed four times in a Tris-buffered solution (TBS; pH 7.5) and incubated in 0.025% diaminobenzidine/0.02% nickel/0.02% H 2 O 2 solution diluted in TBS. This reaction was run for 5 min in each immunocytochemistry experiment and the sections were washed in TBS and stored at 4°C until the tissue was mounted the following day. The controls included looking at an additional GABA A receptor ␣1 antibody with corroborating results and antisera preabsorption, as well as incubation of the tissue without primary antibody.
For generation of BDNF riboprobes, plasmids containing the coding sequence for BDNF (provided by Dr. Keith Parker) were linearized using the appropriate restriction enzyme (PstI, sense; EcoRV, antisense). The linearized DNA was extracted using a standard phenol chloroform extraction. The linearized DNA was then transcribed and DIG labeled using a digoxigenin labeling kit (Roche Applied Science, Indianapolis, IN, USA) and the appropriate RNA polymerase (T3, sense; T7, antisense). The DIG-labeled RNA probes were then precipitated in a solution containing 1 l glycogen (20 mg/ml; Roche Applied Science, Indianapolis, IN, USA), 2.5 l 4 M LiCl, and 75 l cold 100% EtOH. The solution was vortexed briefly, incubated at Ϫ80°C, washed again with 70% EtOH, left to air dry, and resuspended in DEPC water. An optical density reading was obtained to estimate the amount of probe in solution. For BDNF 0.2 g of the riboprobe was added to 1 ml of pre-hybridization buffer for each reaction. Sense probes were generated and used as a control.
For in situ hybridization experiments, tissue was collected using the same methods used for immunocytochemistry but was cut into 100 m sections. The in situ hybridization protocol used was reported previously and was adapted for using free floating sections from previously published methods (Riddle et al., 1993) using polyvinyl alcohol in the reaction product step to enhance detection (De Block and Debrouwer, 1993) . Briefly, the in situ hybridization protocol involved a series of steps occurring over 4 days that included hybridization, washes, and detection using a non-radioactive digoxigenin system. On day 1, agarose-embedded brains were cut into cold DEPC-treated PBS with 12% NaCl and followed by a 1 h bleaching step of 6% H 2 O 2 in PBT (PBS with 0.1% Tween-20) at RT. Sections were then washed with PBT and treated with 10 g/ml proteinase K diluted in PBT, followed by a wash in 2 mg/ml glycine diluted in PBT, rinsed in PBT, then placed in a post-fix solution (4% paraformaldehyde/0.2% glutaraldehyde diluted in PBT) for 20 min. After PBT rinses, the sections were moved to a prehybridization solution (for 40 ml of prehybridization solution: 20 ml formamide, 4 ml 20ϫ SSC, 0.182 ml yeast tRNA, 2 mg heparin, 9.56 ml of 1 g/10 ml solution dextran sulfate, 6.26 ml DEPC H 2 O). The RNA probes were heated to 85°C for 5 min to denature, and riboprobes were then transferred to the vials containing the tissue and prehybridization solution. The sections were left overnight at 60°C to hybridize. The following day the sections were washed with a 50% formamide solution (25% 20ϫ SSC, pH 4.5 and 25% MQH 2 O) in a 60°C shaking waterbath, and then washed in a second solution (50% formamide; 10% 20ϫ SSC, pH 4.5; 40% MQH 2 O) in a 60°C shaking waterbath. The sections were washed at RT in a fresh solution of TBST (1 l solution: 8 g NaCL, 0.2 g KCl, 25 ml 1 M Tris-HCl, 10 ml Tween-20, up to 1 l MQH 2 O). The tissue was placed in a pre-block solution consisting of 10% sheep serum diluted in TBST for at least 1 h at RT and anti-dig-AP antibody (1:2000) in 1% sheep serum/TBST was put into each boat and then shaken overnight at 4°C in a humid chamber. The following day, the antibody was removed and the tissue was washed in TBST. Next, the sections were washed five times in TBST, rocking at RT, and then left overnight in TBST at 4°C. On the final day, the sections were washed in NTMT (2% 5 M NaCl; 5% 2 M Tris, pH 9.5; 5% 1 M MgCl 2 ; 1% Tween-20; diluted in MQH 2 O), and were incubated in 4 ml of a color detection mix in the dark and monitored every 1-2 h for signal detection. The NBT/BCIP color detection mix recipe (25 ml) consists of 12.5 ml 20% polyvinyl alcohol; 12.3 ml 200 mM Tris, pH 9.5; 0.5 ml 5 M NaCl; 0.125 ml 1 M MgCl 2 ; 0.225 ml Levamisol; 0.5 ml NBT/BCIP. Once the reaction was determined complete based on high contrast signal over background, the sections were washed in NTMT, and then washed in a postsubstrate solution (5 ml 1 M Tris-HCl; 1 ml 0.5 M EDTA; 4.5 g NaCl; 0.5 ml MQH 2 O). Following final washes in PBT the sections were stored at 4°C until mounted onto glass slides and coverslipped using aqueous mounting medium.
Slice preparation and live video microscopy
Mice were time mated and fetuses were taken at E14, a developmental age when GABA B receptors are expressed in the hypothalamus in the region of the developing VMN . Pregnant mice were deeply anesthetized with ketamine (80 mg/ kg) and xylazine (8 mg/kg) and fetuses were taken by cesarean section one at a time. The brain, with the pituitary and surrounding cartilage attached, was dissected out of the skull. Dissections were done in Krebs buffer (126 mM NaCl, 2.5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , and 2.5 mM CaCl 2 and an additional 11 mM glucose and 25 mM NaHCO 3 ) on ice and tissue was taken for sex determination (Sry PCR) and genotyping (GABA B PCR). Heads were processed for live slice preparations following previously published methods (Tobet et al., 2003) . Briefly, dissections were limited to a maximum of 2 h or eight pups to minimize cellular damage or death. Following each dissection, brains were embedded in 8% agarose and cut in a coronal plane at 250 m in Krebs buffer using a vibrating microtome (Leica VT1000S). Slices that contained regions of the hypothalamus that included the VMN were chosen for video microscopy and were transferred to media (Neurobasal; GIBCO-Invitrogen Corporation, Carlsbad, CA, USA), with 10% L-glutamine, 2% B-27, 1.1% glucose, 2% pen-strep, 2% glutamine and incubated at 36°C with 5% CO 2 for 35 min. Following the 35-min incubation period, each slice was plated onto glass bottom dishes pre-coated by the manufacturer with poly-Dlysine (MatTek; P35G-0-20-C) and coated with a 1:1 dilution of Vitrogen (Cohesion Technologies, Inc., Palo Alto, CA, USA) and water. The slices were put back into the 36°C incubator for up to 1 h to promote adherence. To ensure that slices would move minimally during video observation, 40 l of a Vitrogen solution (1 ml Vitrogen, 125 l 10XMEM, 23 l penicillin/streptomyocin, and 33 l 1 M sodium bicarbonate) was placed over each slice. The slices were then placed in the 36°C incubator for 1.5 h to allow the Vitrogen to polymerize; 1 ml of Neurobasal medium was pipetted into each dish. The slices were maintained at 36°C and 5% CO 2 until use for video microscopy, as early as the following morning and as late as 3 days postplating.
In preparation for video microscopy, slices were washed three times with warm Neurobasal media (GIBCO-Invitrogen), and placed on a heated stage maintained at 37°C with 5% CO 2 and with fresh Neurobasal medium in the dish. All data were collected on either a Nikon TE200 microscope or a Nikon TE2000-U (Nikon USA, Melville, NY, USA) with a 20ϫ plan Apo phase objective. Cells expressing YFP were imaged using Metamorph software (Molecular Devices Inc., Sunnyvale, CA, USA). A digital camera captured a z-stack series of three images at 5 m intervals through the tissue. A set of three images was taken every 5 min throughout the duration of the video experiment. At least 1.5 h of baseline video microscopy was taken before the addition of GABA receptor antagonists, saclofen (10 M-100 M, GABA B ; SigmaAldrich, St. Louis, MO, USA) or bicuculline (10 M, GABA A ; Sigma-Aldrich). The concentrations used were chosen based on the intent to block GABA signaling through its receptors in live brain slices (Harrison et al., 1990; ). Once a drug was administered to the slice, an additional 1.5 h of video was taken to compare treatments.
Imaging and analysis
For immunocytochemical analysis, each section of tissue that contained a region of the VMN, easily identified based on cell and background density, was labeled as A, B, C, or D; extending from rostral to caudal, respectively (McClellan et al., 2006). Digital images were taken on an Olympus BH2 microscope with an Insight QE digital camera using Spot Advanced software (Draper, UT, USA). Images were taken from the sections labeled B and C, those most centrally located within the nucleus, and then normalized for optimal contrast using Adobe Photoshop software (version CS for Macintosh). For the analysis of cells containing immunoreactive ER␣, images were opened in IP Laboratory software (Scanalytics Inc. part of BD Biosciences, Rockville, MD, USA) and grids (50 mϫ50 m) were placed over the images with the boundaries being the base of the brain and the third ventricle (Davis et al., 2004b) . Rows and columns extended from the base of the brain moving dorsally and laterally from the third ventricle. Row 1 was designated as the row closest to the base of the brain with more than 50% of the boxes containing tissue. Areas were determined following standard segmentation of the most densely reactive cellular elements in each image. The area of ER␣ immunoreactive cells was measured in each box and designated as immunoreactive cells residing in the region of the ARC or VMN. Totals were calculated by region and by row, and statistical significance was determined by ANOVA for genotypeϫage and using row as a repeated measures using SPSS software (SPSS Inc.; Chicago, IL, USA). Immunoreactive SF-1 and the in situ hybridization signal for BDNF were analyzed as total area within the VMN by one-way ANOVA for genotype. As there was no evidence for a heterozygote phenotype for these measures the data depicted is control (wild typeϩheterozygotes) versus homozygous knockout. For dual label fluorescence, images were taken on a Zeiss LSM510 Meta confocal microscope. Video analysis has been described in detail previously (Bless et al., 2005; . Video sequences were evaluated for the presence of visibly moving Thy-1 YFP neurons. These images were aligned to normalize for slice movement using Image J software (NIH, Bethesda, MD, USA), and movement analysis was performed using MetaMorph (Molecular Devices, Downington, PA, USA). A fluorescent cell was "tracked" by manually following the center of each cell and recording the position for each time point. The rate, or average speed, was determined by calculating the speed between each frame and taking an average of all speeds. Data were first collected for all moving cells and later each cell was classified as being part of the VMN or ARC. Data for the current study were collected from 20 slices, from 16 litters. Fig. 1E ). There were no differences seen between the two drug treatment groups or with the location of YFP cells in the nucleus. Sample tracings of individual cells illustrate the distance traveled based on the change in speed before (Fig. 1C) , and after (Fig. 1D ) drug treatment. For comparison, cells in the ARC region were also analyzed for average movement speeds before and after drug treatment. Moving neurons in this region did not respond to the addition of either bicuculline or saclofen (Fig. 1F ). There was a significant difference in the baseline speed between neurons moving in the region of the ARC and VMN. YFP-positive cells in the ARC moved about 30% faster than those in the VMN (F 1,64 ϭ5.45, PϽ0.02 ). The addition of saclofen following bicuculline or bicuculline following saclofen to the slices did not have any additional effects on the rate of motion of cells in the VMN or ARC (data not shown). To control for non-specificity, a cannabi-noid receptor -1 agonist (WIN-55, 100 M; Sigma-Aldrich) was also administered to live slices. The CB-1 receptor mRNA is highly expressed in the VMN of the developing rat (Berrendero et al., 1998) . There were no changes in the movement direction or speed of neurons exposed to this drug (data not shown). To determine if the movement of YFP neurons was affected by the direct response of GABA on these neurons, we looked for the presence of GABA receptors on YFP-positive neurons. YFP-positive neurons in E15 sections were surrounded by a network of immunoreactive GABA B (Fig. 2C ) and GABA A (Fig. 2F and I ) receptor subunits in the VMN. GABA receptors are expressed predominantly in non-nuclear cellular compartments while YFP primarily is a cytoplasmic marker (YFP expression is also seen in the nuclear regions of neurons likely due to leakage of the fluorescent protein). White arrows indicate examples where distinct YFP neurons were surrounded by GABA receptor expression.
RESULTS

GABA receptor antagonists caused an increase in
The distribution of lateral ER␣ immunoreactive neurons was changed in the GABA B R1 knockout while more centrally located cell types (containing immunoreactive SF-1 or BDNF mRNA) were unchanged
To test the hypothesis that alterations in GABA signaling in development affect final cell positioning, we examined brain sections from wild-type and GABA B receptor knock- Fig. 1 . Brain slices 250 m thick were used for the collection of video microscopy data indicating an increase in neuronal movement in the region of the developing VMN but not the ARC in response to GABA antagonists. The entire region of the hypothalamus that includes the VMN and ARC (A) has fluorescently labeled cells located near the ventricles (V). The boxed region represents the region magnified in (B; scale barsϭ100 m). Migrating neurons did not follow strictly radial or dorsal/ventral movement patterns, rather they changed directions and speeds numerous times within any given time period. Scatter plots for VMN (C) and ARC (D) cells represent sample neurons tracked over 90 min time periods (scale barsϭ5 m) with baseline shown on the left and drug response on the right of each panel. Movement did not occur between every frame and some cells appear to have moved more or farther than others. In the VMN (C, E) the baseline speeds were significantly slower than those observed following drug treatment (10 M bicuculline or 10 M-100 M saclofen; data combined and labeled as drug due to both drugs eliciting the same response). There was no change in the average rate of motion for neurons in the region of the ARC following GABAergic manipulation (F). The scales are different between E and F and ARC neurons moved notably faster than those in the region of the VMN. out mice for changes in immunochemically defined cell populations. We looked at the distribution of cells containing immunoreactive ER␣ throughout the VMN. They were densely located in the most ventrolateral region of the VMN at three different developmental ages: E17, P0, and P4. ER␣ immunoreactivity in the GABA B R1 knockout at P0 appeared to shift dorsal to the expression pattern seen in the wild-type ( Fig. 3C and D; genotypeϫlocation, F (10,90) ϭ3.61, PϽ0.01). Although cells were located in more dorsal positions, there was no change in the amount of total immunoreactive area [WT, 30,718Ϯ1568 mean pixels 2 ; KO, 23,954Ϯ1271 mean pixels 2 ; (PϾ0.10)]; the mean total area (mean pixels 2 ) of ER␣ expression remained the same. The change in position that became evident at P0 remained at P4; we saw the same effect, with a more dorsal shift of ER␣ positive cells in the knockout as compared with the wild-type (Fig. 3E and F) with no difference in the total immunoreactive area [WT, 29,785Ϯ3765 mean pixels 2 ; KO, 25,437Ϯ2974 mean pixels 2 ]. At E17, we saw a pattern of immunoreactivity that looked similar to that seen at P0 and P4, however, the difference between genotypes was not statistically significant at this age ( Fig. 3A  and B ) and the total immunoreactive area was unchanged [WT, 27,091Ϯ3836 mean pixels 2 ; KO, 25,559Ϯ5299 mean pixels 2 ]. Fig. 4 shows a graphical representation of the dorsal shift seen in immunoreactive ER␣. There is no significant difference in any of the rows at E17 (Fig. 4A) . At P0, the largest significant difference in ER␣ immunoreactivity is between 100 and 200 m from the base of the brain (Fig.  4B) . A similar pattern is seen at P4 (Fig. 4C) , with the largest significant difference between 200 m and 300 m from the base of the brain. There were no positional changes (medial/lateral or dorsal/ventral) based on ER␣ immunoreactive cells in the ARC at any age examined. We also measured the mean total area of ER␣ in the region of the ARC and found no difference between wild type and GABA B R1 knockout animals at any of the three ages [E17; WT, 30,101Ϯ894 mean pixels 2 ; KO, 28,444Ϯ1420 mean pixels 2 , P0; WT, 30,170Ϯ3299 mean pixels 2 ; KO, 32,570Ϯ5612 mean pixels 2 , P4; WT, Fig. 2 . Dual label images of Thy-1 driven immunoreactive YFP in neurons and GABA receptor subunits. Immunoreactive GABA B receptor subunit R1 (A), and GABA A receptor subunits ␣1 (D) and ␤3 (G) were found in both VMN and ARC (not shown) at E15. YFP containing neurons were surrounded by networks of GABA receptor subunit expression (C, F, I). White arrows indicate example cells that appear to show colocalization. For GABA B R1 and GABA A ␤3 subunits, immunoreactivity within the VMH was apparent in virtually all cells in non-nuclear compartment(s) whereas immunoreactive GABA A ␣1 subunits were found in a subset of cells (also in non-nuclear cellular compartments). Images were taken on a confocal microscope with a 1.6 m optical slice (scale barsϭ50 m).
38,020Ϯ3611 mean pixels 2 ; KO, 41,267Ϯ3660 mean pixels 2 (PϾ0.10)]. To determine if GABA signaling through the GABA B receptor affects all cell types within the VMN, we also examined changes in the position (using the grid system as described above) or expression (total immunoreactive area) of neurons expressing immunoreactive SF-1 protein or BDNF mRNA (by in situ hybridization). SF-1 and BDNF are localized in cells of the more dorsal and central regions of the VMN (Tran et al., 2006 ). In the GABA B R1 knockout the expression of these two markers was unchanged in both amount and position indicating that not all phenotypically identified cells of the VMN have altered positions in the GABA B R1 knockout (Fig. 5) .
To determine if the change in position seen in ER␣ positive cells in the ventrolateral quadrant of the VMN (vlVMN) of GABA B R1 knockout mice was due to a disruption in radial fibers, sections containing regions of the VMN and ARC were processed for Thy-1 YFP (green) immunoreactivity and RC2 immunoreactive radial fibers (red). Tissue sections were taken from a mouse line generated by crossing the GABA B R1 heterozygote with a Thy-1/YFP mouse resulting in mice that were knockouts, heterozygotes, or wild-type for the GABA B R1 gene and contained YFP expressing Thy-1 neurons. There were no apparent alterations of radial fibers in the GABA B R1 knockout mouse (Fig. 6B) as compared with those in wild-type littermates (Fig. 6A) . The presence of intact radial fibers suggests that the altered positions of ER␣ immunoreactive neurons in GABA B R1 knockout mice were not due to the lack of or the severing of fibers that guide neuronal migration.
A small subset of Thy-1 YFP-positive neurons expresses islet-1 and ER␣ in the VMN and ARC
To determine if neurons containing YFP also expressed ER␣, we utilized tissue sections from E15 Thy-1/YFP mice to look for colocalization. In the VMN (Fig. 7C) we found 3.3% Ϯ1.2 (nϭ4) of YFP neurons colocalized with immunoreactive nuclear ER␣. In the ARC (Fig. 7F) , there was more colocalization of ER␣ and YFP (6.7%Ϯ2.4, nϭ3), which may be due to the abundance of YFP neurons in the ARC at this age. ER␣ and islet-1 immunoreactive neurons localize to the ventrolateral quadrant of the VMN where most islet-1 neurons are also ER␣ immunoreactive (Davis et al., 2004b) . There was no significant difference in the amount of YFP-positive neurons that colocalized with islet-1 versus ER␣ in the VMN (7.9%Ϯ2.9) or the ARC (13.9%Ϯ7.5) (white arrows in Fig. 7I ). Despite the low levels of YFP-ER␣ and YFP-islet-1 colocalization at E15, it is still possible that a number of the YFP neurons viewed in live video microscopy become ER positive at later points in development. However, at the time points examined, they are not ER positive and may represent other cell phenotypes within the VMN and ARC.
DISCUSSION
The diencephalon can be parceled into major regions based on transcription factor expression (Puelles and Rubenstein, 2003; Lim and Golden, 2007) and some information is emerging relative to expression of transcription factors within the hypothalamus (Caqueret et al., 2006) . Much less, however, is known concerning the details by which specific nuclear groups emerge from early transcriptional coding ( (Fig. 8C, D) . The actions of GABA cannot explain all of VMN formation (e.g. no influence of GABA receptor modifications on medial and centrally located cells containing immunoreactive SF-1; Fig. 5 and Fig. 8 ). As an effective signaling molecule, however, it likely plays a key role in fine-tuning the positions of some VMN neurons and ultimately their connectivity.
The results of the current study provide evidence that endogenous GABA signaling affects the rates of cell motion in the region of the developing VMN, but does not alter the rate of motion in the ARC. GABA receptor antagonist administration led to an increase in the rate of motion in cells of the VMN suggesting that normal GABA signaling decreases or inhibits cell motion. These results were seen in fluorescently labeled Thy-1/YFP cells, located near the ventricular zone, which represent a subpopulation of VMN neurons. At E14/15, the ages used for live video microscopy ( Fig. 1 ) and dual label immunocytochemistry (Fig. 2) , the VMN and ARC are becoming distinct nuclear regions through the movement, positioning, and differentiation of Fig. 4 . Graphic representation of the area of ER␣ immunoreactivity in GABA B R1 wild-type and knockout mice at three developmental ages. Bar graphs illustrate the immunoreactivity seen in each row based on a grid system with the first row along the base of the brain (nϭ6 for each genotype at each age). At P0 (B), the peak of immunoreactivity in the wild-type animal is between 150 and 200 m from the base of the brain and the peak of immunoreactivity in the KO animal is between 250 and 300 m from the base of the brain (scale barsϭ100 m). At P4 (C), the peak of immunoreactivity in the wildtype is around 250 m from the base of the brain while the peak in immunoreactivity for the knockout animal ranged from 300 to 400 m from the base of the brain. There were significant differences between the wild-type and knockout animals at these two ages (genotypeϫposition interaction, PϽ0.05). There were no significant differences at E17 (A).
various cell types. There is little evidence that these cells within the VMN, or those that will project to the VMN have begun to extend processes. Evidence of VMN projections had been described at 1 week postnatal with processes projecting from the amygdala to the VMN (Choi et al., 2005) . Early signs of dendritic development in the rat VMN were also seen as primarily postnatal (Crandall et al., 1989 ). An alteration in migratory responses could be related to alterations in connectivity as suggested in discussions of roles for Reelin in hippocampal development (Del Rio et al., 1997). 6 . Dual label images show immunoreactive Thy1/YFP (green) and RC2 (red) in the GABA B R1 wild-type (A) and knockout (B) mouse. Radial fibers were intact in the knockout mouse suggesting that altered neuronal movement seen in Thy1/YFP-positive neurons was not due to severed or misdirected radial fibers (scale barsϭ100 m; standard epifluorescence microscopy). GABA B R1 (C) and ER␣ (D) appear to localize in the same cells (example at white arrow). As GABA B R1 is a receptor found on the cell surface and ER␣ is a nuclear receptor it is difficult to conclude definitive colocalization. Images C, D, and E were taken using a confocal microscope with an optical slice of 1.6 m.
Determining influences on connectivity is a topic that needs to be addressed based on the current results.
The mechanism(s) through which GABA may act as a migratory cue involves direct ligand/receptor interactions that ultimately influence cells to change rates of motion. The administration of GABA receptor antagonists increased the average speeds of neurons that were already moving in the slice preparation (motion when all frames averaged), but did not alter the likelihood of cell movement (percent of frames with motion). GABA can act through two different receptor subtypes that utilize two different mechanisms, but in the current results, they resulted in the same effect on cell motions. GABA B receptors are metabotropic G-protein-coupled receptors (Gi/o) that activate cGMPsignaling pathways, activating potassium channels and altering calcium currents, changing the calcium concentration within cells (Bowery and Brown, 1997) . These receptors are different in both structure and mechanism from GABA A receptors, which signal through the movement of chloride along its concentration gradient, changing the membrane potential of cells. However, since chloride moves outward in embryonic neurons causing depolarization and potential calcium entry (Gao and van den Pol, 2000), one possible common mechanism through which GABA may be influencing cell speed is through changes in intracellular calcium levels. The location of GABA A and GABA B receptors on the same cells in hypothalamic neurons has been shown to influence the behavior of the neurons. GABA B receptor-mediated inhibition has been shown to affect GABA A receptor-mediated calcium spikes in embryonic hypothalamic neurons (Obrietan and van den Pol, 1998). In the current study, there was no additive effect of sequential addition of GABA A and GABA B antagonists further suggesting that the influence on motion was through a common mechanism.
The finding that cell motions are influenced by GABA signaling leads to the hypothesis that GABA signaling plays a role in determining cell positions within the VMN. GABA receptor antagonists influenced movements independent of the location within the developing nucleus. Thy-1/YFP-labeled neurons examined in our live video microscopy studies move in two distinct directions; dorsal/ ventral parallel to the third ventricle, and laterally along radial glial fibers. The majority of the fluorescently labeled cells examined in this movement analysis were located close to the third ventricle. When the data were analyzed separately for location (along the third ventricle or slightly more lateral) there were no differences in movement speeds between locations or in the orientation of the cells (data not shown). As the majority of VMN neurons express specific subunits of the GABA A receptor and/or the GABA B receptor , and the response to drug administration was relatively rapid, it is likely that the drug influence was direct to the moving cells. The specific subpopulation of YFP neurons being tracked for motion appears to be neurons that contain GABA receptors themselves. GABA A and GABA B subunit immunoreactivity appears to be in YFP containing neurons. It is difficult to determine if these are the same cells due to the pattern of immunoreactivity with GABA receptors apparent in non-nuclear cellular compartments and YFP being largely cytoplasmic. Cell movement in the ARC was measured before and after GABA receptor manipulation. Although the ARC also contains neurons expressing GABA receptors , cells in this region did not respond to GABA antagonists. This may be caused by a desensitization to GABA as many neurons in the ARC either synthesize GABA themselves or are surrounded by fibers and neurons that synthesize GABA (Figs. 3, 4,  8D) . The R1 subunit of the GABA B receptor contains the ligand binding domain for the GABA B receptor, therefore, the disruption of this subunit globally effects the function of this receptor and its ability to bind GABA (Jones et al., 1998) . The pharmacological effects of GABA B antagonism (increased motion; Fig. 1 ) on the movement of Thy1/YFP cells in vitro are a logical candidate as a mechanism for cell displacement in the GABA B R1 subunit knockout mice. Although immunoreactive ER␣ and islet-1 were seen in few YFP containing neurons at E15, Thy-1/YFP neurons were found in the ventrolateral quadrant of the VMN. The matching of YFP fluorescence to identified lateral VMN components was incomplete at the ages that motion was examined due to either low expression or antisera ability to detect immunoreactive ER␣. The islet-1 immunoreactive cell population at E15 represented a greater population of ventrolateral neurons and therefore more colocalization with YFP may have been due to an increase in the number of islet-1 immunoreactive cells in the ventrolateral VMN. Nonetheless, it is likely that neurons that express ER␣ are influenced by the surrounding gradient of GABA based on several lines of evidence. First, a previous study showed a more widespread localization of cells containing immunoreactive ER␣ in mice lacking the ␤3 subunit of the GABA A receptor ; Fig. 8C ). Genetic disruption of this subunit has been shown to decrease GABA A signaling by up to 50% (Homanics et al., 1997). Second, in SF-1 knockout mice there is a massive reorganization of the region of the VMN and one of the first things altered is the pattern of GABAergic elements (Dellovade et al., 2000; Fig. 8B ). Finally, in the current study, genetic disruption of the R1 subunit of the GABA B receptor resulted in a dorsal shift in cells containing immunoreactive ER␣ (Fig. 8D) . More studies are needed to determine other subgroups of cells that co-label with YFP and that may be influenced by secreted signaling molecules like GABA. Interestingly, cells containing BDNF mRNA or immunoreactive SF-1 that are localized to the dorsomedial and central regions of the VMN were not influenced by the absence of functional GABA B receptors.
The response to antagonist in the current study is further evidence that cells in the region of the VMN respond to endogenous GABAergic signals. Previous work showed that immunoreactive GAD continues to encircle the developing VMN in brain slices up to 3 days in vitro . Transcription factors (e.g. SF-1) play key roles in determining pattern formation in the developing nervous system. However, transcription factors do not by themselves signal between cells in development; effector molecules like GABA may play key roles in translating nuclear decisions (e.g. GAD transcription) into cellular behaviors . In the embryonic mouse brain, GABA is found in a number of regions, where it may play role(s) unlike its more widely studied function in adult brain. In development, GABA has been shown to be excitatory (Obrietan and van den Pol, 1995), as well as influencing processes such as neuronal proliferation and migration . The large amounts of GABA that are synthesized along with the lack of developed synapses led to the belief that the role GABA plays as a paracrine factor during development of the hypothalamus is unlike its function at the synapse (Taylor et al., 1990 ; Gao and van den Pol, 2000; Manent and Represa, 2007) . GABA receptors are expressed within neurons as early as E13 and are likely capable of responding to GABA that may be secreted at the boundaries of the VMN at these early ages.
CONCLUSION
In summary, the current study has taken two independent lines of evidence to converge on the potential role of GABAergic stimulation on hypothalamic nuclear development. In vitro evidence showed that the manipulation of GABA receptors altered the motion of a specific subpopulation of neurons within the VMN but not the ARC. This result provides evidence that GABAergic stimulation is relevant to specific regions in the hypothalamus (VMN) while other regions, for reasons yet to be determined, are not responsive. The same result (an increase in motion) was seen upon the addition of either GABA A or GABA B antagonists leading to the conclusion that although the initial mechanisms may differ, GABA action through either receptor may ultimately invoke a common mechanism. In vivo evidence using mice in which the GABA B receptor was disrupted showed that mice lacking this receptor in development exhibited phenotypic changes within the hypothalamus; including, changes in the position of cells in the VMN suggesting significant long term consequences of these developmental actions. These lines of evidence emphasize the importance of GABA and GABA receptors in the development of specific regions or nuclei within the hypothalamus. Further experiments are needed to determine if altered movement eventually leads to altered functional characteristics or synaptic connections within the developing brain.
